Effects of Physical Activity During Pregnancy on the Newborn's Cognitive Function

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Université de Montréal.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Université de Montréal
ClinicalTrials.gov Identifier:
NCT01220778
First received: October 13, 2010
Last updated: NA
Last verified: September 2010
History: No changes posted
  Purpose

Background: It is now generally accepted that an active lifestyle is beneficial for cognition, but can these benefits be transmitted for the active pregnant woman to her unborn child? This has been demonstrated in rats where the pups born of mothers who exercised during pregnancy had increased hippocampal neurogenesis and better memory and learning capabilities. Human studies tend to confirm this by looking at behavioral results, ie. better orientation and state regulation skills in newborns. The aim of the present study is to verify this on the electrophysiological level and to determine the effects of an active lifestyle during pregnancy on the newborn's brain development.

Methods: 60 pregnant women will be included in a randomized controlled trial. The exercise group will be asked to exercise a minimum of 20 minutes, 3 times per week, at a minimal intensity of 55% of their maximal aerobic capacity. The control group will not be given exercise counselling. Newborns' brain activity will be recorded using electroencephalography (EEG) 10 days post partum. The primary outcome measure will be the amplitude and latency of the mismatch negativity (MMN), a component of the auditory event-related potential (ERP) that can be used to investigate the auditory sensory memory.


Condition Intervention
Pregnancy
Behavioral: Exercise

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Official Title: Effects of Physical Activity During Pregnancy on the Newborn's Cognitive Function, the Healthy Mom, Bright Child Randomized Trial

Resource links provided by NLM:


Further study details as provided by Université de Montréal:

Primary Outcome Measures:
  • Mismatch negativity

Arms Assigned Interventions
Experimental: Exercise Behavioral: Exercise
No Intervention: Control

  Eligibility

Ages Eligible for Study:   20 Years to 35 Years
Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • First trimester of pregnancy
  • 20 to 35 years of age
  • Pre-pregnancy BMI between 18 and 25
  • Primipara
  • Without any known health issues
  • Use of folic acid

Exclusion Criteria:

  • Use of alcohol, cigarettes or illegal drugs
  • Pregnancy complications
  • Unable or unwilling to breastfeed
  • Excessive or insufficient weight gain
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01220778

Contacts
Contact: Elise L. LeMoyne 514-343-6111 ext 5380 apgrossesse@kinesio.umontreal.ca

Locations
Canada, Quebec
Cepsum Recruiting
Montreal, Quebec, Canada, H3T1J4
Contact: Elise L.LeMoyne    514-343-6111 ext 5380    apgrossesse@kinesio.umontreal.ca   
Sponsors and Collaborators
Université de Montréal
Investigators
Principal Investigator: Elise L.LeMoyne Université de Montréal
  More Information

Additional Information:
No publications provided by Université de Montréal

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT01220778     History of Changes
Other Study ID Numbers: CERSS-2010-951-P
Study First Received: October 13, 2010
Last Updated: October 13, 2010
Health Authority: Canada: Canadian Institutes of Health Research
Canada: Ethics Review Committee
Canada: Health Canada

ClinicalTrials.gov processed this record on October 19, 2014